6533b873fe1ef96bd12d57ab

RESEARCH PRODUCT

Serological Evidence for Multiple Strains of Canine Norovirus in the UK Dog Population

S CaddyE EmmottL El-attarJ. MitchellAlexis De RougemontJoe BrownlieIan Goodfellow

subject

Veterinary medicineTime Factorsgenetic structuresSerological evidencelcsh:Medicinemedicine.disease_causeAntibodies ViralSeroepidemiologic Studies[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseaseslcsh:Science[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology0303 health scienceseducation.field_of_studyMultidisciplinarybiologyGeneral Medicine3. Good health[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRNA ViralAntibodyGeneral Agricultural and Biological SciencesResearch ArticlePopulationCross ReactionsGeneral Biochemistry Genetics and Molecular BiologyVirusSingle strain03 medical and health sciencesDogsSpecies SpecificitymedicineSeroprevalenceAnimalsSerologic Testseducation030304 developmental biology030306 microbiologybusiness.industrylcsh:RNorovirusSerum samplesVirologyUnited Kingdomeye diseasesNorovirusbiology.proteinlcsh:Qsense organsbusiness

description

International audience; Noroviruses are associated with intestinal disease in humans, cows, pigs, mice, and, more recently, dogs. In 2007, the first canine norovirus (CNV) was identified and characterized in Italy. Subsequent studies have identified CNV in stools of dogs from Portugal, Greece, and the United States. To investigate the prevalence of CNV in the UK dog population, 228 canine stool samples were screened for CNV by qPCR, and 396 serum samples were screened for anti-CNV antibodies. qPCR of RNA extracted from canine stool samples did not reveal any CNV-positive samples, based on samples collected from diarrhoeic and control dogs in 2012-2013. CNV virus-like particles to three different CNV strains were produced using recombinant baculoviruses and a seroprevalence screen undertaken. Anti-CNV antibodies were identified at significant levels in canine serum; 38.1% of samples collected between 1999-2001 and 60.1% of samples collected in 2012-2013 were seropositive. The increase in seroprevalence over time (p,0.001) suggests that the CNV strains screened for are becoming more widespread. Variation in seroprevalence to different CNV strains was also identified. Two-thirds of the dogs were seropositive to a single strain, whereas the remaining third were seropositive to two or three of the strains analysed. This study has provided the first evidence that CNV is present in the UK, with seroprevalence identified to multiple circulating strains. This warrants further study and increased awareness of this recently discovered canine virus.

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-02290995/document